Molina Healthcare, Inc. (NYSE:MOH) Stock Holdings Raised by Greenleaf Trust

Greenleaf Trust raised its stake in Molina Healthcare, Inc. (NYSE:MOH) by 15.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 961 shares of the company’s stock after purchasing an additional 130 shares during the period. Greenleaf Trust’s holdings in Molina Healthcare were worth $257,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Rhumbline Advisers boosted its holdings in shares of Molina Healthcare by 5.0% in the 1st quarter. Rhumbline Advisers now owns 137,683 shares of the company’s stock valued at $36,829,000 after buying an additional 6,577 shares during the period. Mount Yale Investment Advisors LLC acquired a new position in shares of Molina Healthcare in the 1st quarter valued at about $981,000. Commonwealth Equity Services LLC boosted its holdings in shares of Molina Healthcare by 1.6% in the 1st quarter. Commonwealth Equity Services LLC now owns 17,463 shares of the company’s stock valued at $4,671,000 after buying an additional 273 shares during the period. Citigroup Inc. boosted its holdings in shares of Molina Healthcare by 128.2% in the 1st quarter. Citigroup Inc. now owns 114,780 shares of the company’s stock valued at $30,703,000 after buying an additional 64,492 shares during the period. Finally, Guggenheim Capital LLC boosted its holdings in shares of Molina Healthcare by 39.6% in the 1st quarter. Guggenheim Capital LLC now owns 11,440 shares of the company’s stock valued at $3,060,000 after buying an additional 3,248 shares during the period. Institutional investors own 98.11% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 12,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $302.77, for a total value of $3,784,625.00. Following the transaction, the insider now owns 64,973 shares in the company, valued at approximately $19,671,875.21. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Molina Healthcare news, Director Steven J. Orlando sold 723 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $301.25, for a total value of $217,803.75. Following the transaction, the director now owns 20,265 shares in the company, valued at approximately $6,104,831.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Jeff D. Barlow sold 12,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $302.77, for a total transaction of $3,784,625.00. Following the completion of the transaction, the insider now owns 64,973 shares in the company, valued at approximately $19,671,875.21. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,246 shares of company stock worth $5,247,256. 1.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. Truist Financial decreased their price target on shares of Molina Healthcare from $380.00 to $365.00 in a report on Tuesday, June 20th. Bank of America boosted their target price on shares of Molina Healthcare from $340.00 to $350.00 in a research note on Thursday, July 27th. Morgan Stanley reissued an “overweight” rating and set a $365.00 target price on shares of Molina Healthcare in a research note on Friday, July 14th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Molina Healthcare from $365.00 to $335.00 in a research report on Monday, May 8th. Finally, StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Molina Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $350.92.

Molina Healthcare Stock Up 0.7 %

MOH stock opened at $321.22 on Tuesday. Molina Healthcare, Inc. has a 52-week low of $256.19 and a 52-week high of $374.00. The company’s 50 day simple moving average is $305.06 and its 200-day simple moving average is $290.69. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.52 and a quick ratio of 1.52. The firm has a market capitalization of $18.73 billion, a P/E ratio of 20.36, a P/E/G ratio of 1.08 and a beta of 0.69.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, July 26th. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.05 by $0.60. Molina Healthcare had a net margin of 2.81% and a return on equity of 35.87%. The business had revenue of $8.33 billion for the quarter, compared to analyst estimates of $8.32 billion. During the same quarter in the previous year, the business earned $4.55 earnings per share. The firm’s revenue was up 3.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Molina Healthcare, Inc. will post 20.78 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.